Back to Agenda
Session 0401: STATISTICAL LEADERSHIP IN PHARMACEUTICAL DEVELOPMENT AND BIOSTATISTICIAN'S ROLE IN REGULATORY ADVISORY MEETINGS
Session Chair(s)
Tony Guo
SVP, Global Head of Statistics and Data Science
BeiGene, China
As pharmaceutical development relies increasingly on data driven and quantitative principles, statistical scientists are playing important roles not only in pharmaceutical development design and execution, but also in the regulatory submission and review process (including the critical advisory review meetings). In this session we will invite top statistical leaders from academia, government and industry to discuss the opportunities and challenges facing the profession.
Speaker(s)
Statistical Leadership in Regulatory Agency and Academia
Lisa LaVange, PHD
University of North Carolina at Chapel Hill, United States
Professor Emerita
Statistical Leadership in Pharmaceutical Industry
Jerald Schindler, DrPH
Strategic Statistics, United States
Chief Executive Officer
Feng Chen, PHD
School of Public Health, Nanjing Medical University, China
Professor, Dean
Marcia Levenstein
Pfizer, United States
Vice President and Head of Global Statistics, Specialty Care Business Unit
Have an account?